Independent Solutions Wealth Management, LLC Astrazeneca PLC Transaction History

Independent Solutions Wealth Management, LLC

$442 Billion
Q3 2024

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Dec 19, 2024	SELL	$64.85 - $71.7 $13,877 - $15,343	-214 Reduced 2.06%	10,169 $689 Million
Q2 2023 Dec 19, 2024	BUY	$69.91 - $75.81 $111,786 - $121,220	1,599 Added 18.2%	10,383 $743 Million
Q1 2023 Dec 19, 2024	BUY	$63.15 - $71.6 $5,115 - $5,799	81 Added 0.93%	8,784 $610 Million
Q4 2022 Dec 19, 2024	SELL	$54.21 - $70.44 $8,131 - $10,566	-150 Reduced 1.69%	8,703 $590 Million
Q3 2022 Dec 19, 2024	SELL	$53.02 - $135.75 $3,764 - $9,638	-71 Reduced 0.8%	8,853 $486 Million
Q2 2022 Dec 19, 2024	BUY	$59.26 - $71.14 $184,061 - $220,960	3,106 Added 53.39%	8,924 $590 Million
Q1 2022 Dec 19, 2024	BUY	$55.72 - $67.12 $53,546 - $64,502	961 Added 19.79%	5,818 $386 Million
Q4 2021 Dec 19, 2024	BUY	$54.02 - $63.83 $47,807 - $56,489	885 Added 22.28%	4,857 $283 Million
Q3 2021 Dec 19, 2024	BUY	$55.56 - $60.79 $220,684 - $241,457	3,972 New	3,972 $239 Million

Others Institutions Holding AZN

# of Institutions

1,361

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

Price T Rowe Associates Inc Baltimore, MD

62.9M
Shares

$4.11 Billion
0.56% of portfolio
Primecap Management CO Pasadena, CA

42M
Shares

$2.74 Billion
2.45% of portfolio
Wellington Management Group LLP Boston, MA

37.2M
Shares

$2.43 Billion
0.52% of portfolio
Capital International Investors Los Angeles, CA

36.8M
Shares

$2.41 Billion
0.57% of portfolio
Franklin Resources Inc San Mateo, CA

19.1M
Shares

$1.25 Billion
0.45% of portfolio

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $203B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Independent Solutions Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Independent Solutions Wealth Management, LLC with notifications on news.

Account